Maternal Proton Pump Inhibitor Use During Pregnancy and Risk of Low Birth Weight in Offspring in Korea, 2008-2019
Sign Up to like & getrecommendations! Published in 2023 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2023.7962
Abstract: This cohort study examines whether the risk of low birth weight is associated with prenatal exposure to proton pump inhibitors. read more here.
Keywords: birth weight; proton pump; risk low; low birth ... See more keywords
Laterally Heterogeneous 2D Layered Materials as an Artificial Light‐Harvesting Proton Pump
Sign Up to like & getrecommendations! Published in 2020 at "Advanced Functional Materials"
DOI: 10.1002/adfm.202001549
Abstract: Heterogeneous structures in nacre‐mimetic 2D layered materials generate novel transport phenomena in angstrom range, and thus provide new possibilities for innovative applications for sustainable energy, a clean environment, and human healthcare. In the two orthogonal… read more here.
Keywords: light harvesting; layered materials; proton; harvesting proton ... See more keywords
Nano-Enabled Reposition of Proton Pump Inhibitors for TLR Inhibition: Toward A New Targeted Nanotherapy for Acute Lung Injury.
Sign Up to like & getrecommendations! Published in 2021 at "Advanced science"
DOI: 10.1002/advs.202104051
Abstract: Toll-like receptor (TLR) activation in macrophages plays a critical role in the pathogenesis of acute lung injury (ALI). While TLR inhibition is a promising strategy to control the overwhelming inflammation in ALI, there still lacks… read more here.
Keywords: proton pump; nano enabled; tlr; lung injury ... See more keywords
Bioequivalence and Relative Bioavailability Studies to Assess a New Acalabrutinib Formulation That Enables Coadministration With Proton‐Pump Inhibitors
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Pharmacology in Drug Development"
DOI: 10.1002/cpdd.1153
Abstract: Acalabrutinib is a Bruton tyrosine kinase (BTK) inhibitor approved to treat adults with chronic lymphocytic leukemia, small lymphocytic lymphoma, or previously treated mantle cell lymphoma. As the bioavailability of the acalabrutinib capsule (AC) depends on… read more here.
Keywords: proton pump; coadministration proton; bioavailability; pump inhibitors ... See more keywords
Association between proton pump inhibitors and periodontal disease severity.
Sign Up to like & getrecommendations! Published in 2021 at "Clinical and experimental dental research"
DOI: 10.1002/cre2.495
Abstract: OBJECTIVES Proton pump inhibitors (PPIs) are commonly prescribed for the management of acid-related gastrointestinal disorders. PPIs modulate osteoclast function, reduce gastric acid secretion, and are associated with the establishment of a more diverse gastrointestinal microbiota.… read more here.
Keywords: proton pump; pump inhibitors; periodontal disease; probing depths ... See more keywords
The influence of proton pump inhibitors on tissue attachment around teeth and dental implants: A scoping review
Sign Up to like & getrecommendations! Published in 2022 at "Clinical and Experimental Dental Research"
DOI: 10.1002/cre2.616
Abstract: Proton pump inhibitors, such as omeprazole and pantoprazole, are frequently prescribed for the treatment of acid reflux. However, those medications have been shown to affect a variety of physiologic processes, including bone homeostasis and the… read more here.
Keywords: proton pump; teeth dental; around teeth; pump inhibitors ... See more keywords
Proton pump inhibitors, Enterococcus, and the liver, oh my!
Sign Up to like & getrecommendations! Published in 2018 at "Hepatology"
DOI: 10.1002/hep.29822
Abstract: humans. The need for a new model of HCV infection is acute. DAA therapy will likely have limited impact on HCV disease burden in the foreseeable future. Most HCV infections are undiagnosed and virus transmission… read more here.
Keywords: pump inhibitors; hcv; infection; enterococcus liver ... See more keywords
Letter to the Editor: Proton Pump Inhibitors Are Associated With Minimal and Overt Hepatic Encephalopathy and Increased Mortality in Patients With Cirrhosis
Sign Up to like & getrecommendations! Published in 2019 at "Hepatology"
DOI: 10.1002/hep.30641
Abstract: We read the paper by Nardelli et al with great interest.1 The study tried to establish the correlation between using of proton pump inhibitors (PPIs) and the occurrence of minimal/overt hepatic encephalopathy (HE) among cirrhotics. In… read more here.
Keywords: pump inhibitors; minimal overt; hepatic encephalopathy; proton pump ... See more keywords
Confounded association between proton pump inhibitor use and risk of biliary tract cancer: Result from three cohorts.
Sign Up to like & getrecommendations! Published in 2023 at "International journal of cancer"
DOI: 10.1002/ijc.34572
Abstract: Recent epidemiological studies suggested that proton pump inhibitor (PPI) use was associated with an increased risk of biliary tract cancer (BTC), however, confounders were not adequately controlled. Our study aimed to evaluate PPI use and… read more here.
Keywords: btc; proton pump; pump inhibitor; risk ... See more keywords
Proton pump inhibitors: Review of reported risks and controversies
Sign Up to like & getrecommendations! Published in 2018 at "Laryngoscope Investigative Otolaryngology"
DOI: 10.1002/lio2.187
Abstract: Proton pump inhibitors (PPIs) are among the most prescribed classes of drugs in this day and age. These may be beneficial to treat many gastrointestinal conditions, such as gastroesophageal reflux or Barrett's esophagus as well… read more here.
Keywords: pump inhibitors; reported risks; review reported; inhibitors review ... See more keywords
Long‐term use of proton pump inhibitors and prevalence of disease‐ and drug‐related reasons for gastroprotection—a cross‐sectional population‐based study
Sign Up to like & getrecommendations! Published in 2017 at "Pharmacoepidemiology and Drug Safety"
DOI: 10.1002/pds.4135
Abstract: To analyse the prevalence of long‐term use of proton pump inhibitors (PPI) with respect to underlying diseases and drugs, and to find predictors for such treatment when an evident rationale for the PPI treatment is… read more here.
Keywords: pump inhibitors; long term; use proton; proton pump ... See more keywords